Literature DB >> 28337278

Synthesis of huaicarbon A/B and their activating effects on platelet glycoprotein VI receptor to mediate collagen-induced platelet aggregation.

Hongli Yu1, Yeqing Chen2, Hao Wu1, Kuilong Wang2, Liping Liu2, Xingde Zhang2.   

Abstract

Quercetin and rhamnose were efficiently converted into huaicarbon A/B by heating at 250°C for 10-15 min or at 200°C for 25-30 min. With the optimum molar ratio of quercetin/rhamnose (1:3), huaicarbon A and B yields reached 25% and 16% respectively after heating at 250°C, with 55% quercetin conversion. Huaicarbon A/B both promoted washed platelet aggregation dose-dependently, which was antagonized by an inhibitor of glycoprotein VI (GPVI) receptor. Similarly, they both promoted collagen-induced platelet aggregation in platelet-rich plasma in dose-dependent manners. According to the S type dose-response model, EC50 values of huaicarbon A and huaicarbon B were calculated as 33.48 μM and 48.73 μM respectively. They induced intracellular Ca2+ accumulation that was specifically blocked by GPVI antagonist. Huaicarbon A/B enhanced intracellular Ca2+ accumulation and facilitated collagen-induced platelet aggregation, which were blocked by GPVI antagonist. They were conducive to collagen-induced platelet aggregation by activating platelet GPVI receptor.

Entities:  

Keywords:  Heating reaction; huaicarbon A/B; quercetin; rhamnose

Year:  2017        PMID: 28337278      PMCID: PMC5340685     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  15 in total

Review 1.  Collagen-platelet interactions: recognition and signalling.

Authors:  Richard W Farndale; Pia R Siljander; David J Onley; Pavithra Sundaresan; C Graham Knight; Michael J Barnes
Journal:  Biochem Soc Symp       Date:  2003

Review 2.  Platelets at work in primary hemostasis.

Authors:  Katleen Broos; Hendrik B Feys; Simon F De Meyer; Karen Vanhoorelbeke; Hans Deckmyn
Journal:  Blood Rev       Date:  2011-04-14       Impact factor: 8.250

Review 3.  GPVI and CLEC-2 in hemostasis and vascular integrity.

Authors:  S P Watson; J M J Herbert; A Y Pollitt
Journal:  J Thromb Haemost       Date:  2010-03-25       Impact factor: 5.824

4.  Tracing novel hemostatic compounds from heating products of total flavonoids in Flos Sophorae by spectrum-effect relationships and column chromatography.

Authors:  Yeqing Chen; Hongli Yu; Hao Wu; Yaozong Pan; Kuilong Wang; Liping Liu; Yangping Jin; Chenchao Zhang
Journal:  J Sep Sci       Date:  2015-04-17       Impact factor: 3.645

5.  Studies on the antihemostatic substances in herbs classified as hemostatics in traditional Chinese medicine. I. On the antihemostatic principles in Sophora japonica L.

Authors:  H Ishida; T Umino; K Tsuji; T Kosuge
Journal:  Chem Pharm Bull (Tokyo)       Date:  1989-06       Impact factor: 1.645

Review 6.  Platelet glycoprotein VI: its structure and function.

Authors:  Masaaki Moroi; Stephanie M Jung
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

Review 7.  Calcium signaling in platelets.

Authors:  D Varga-Szabo; A Braun; B Nieswandt
Journal:  J Thromb Haemost       Date:  2009-04-24       Impact factor: 5.824

Review 8.  Cell adhesion mechanisms in platelets.

Authors:  David Varga-Szabo; Irina Pleines; Bernhard Nieswandt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-03       Impact factor: 8.311

9.  The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke.

Authors:  Silvia Goebel; Zhongmin Li; Jasmin Vogelmann; Hans-Peter Holthoff; Heidrun Degen; Dirk M Hermann; Meinrad Gawaz; Martin Ungerer; Götz Münch
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

10.  A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo.

Authors:  Steffen Massberg; Meinrad Gawaz; Sabine Grüner; Valerie Schulte; Ildiko Konrad; Dietlind Zohlnhöfer; Ulrich Heinzmann; Bernhard Nieswandt
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.